source
- Adaptyv Bio shares results from its latest AI-driven protein design contestAdaptyv Bio, a biotech firm focused on protein engineering, released the outcomes of its newest competition that tests how well artificial‑intelligence models can create novel proteins. The challe…
- Intellia's in-body CRISPR therapy achieves first Phase 3 successIntellia announced that its experimental in vivo CRISPR gene‑editing therapy has completed a Phase 3 trial with positive results. This is the first instance of a CRISPR‑based treatment delivered d…